Dossier assessment

Ibrutinib (new therapeutic indication) - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)

Status
Status: Withdrawn commission
Project no.
G15-07
Last updated

Project details

Project no.
G15-07
Commission
Commission awarded on 01.08.2015 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Withdrawn commission
Department/Division
Health Economics
Topic
Cancer
Note

The commission was withdrawn by the Federal Joint Committee in agreement with IQWiG on 15.10.2015. G-BA documents on this decision

Connected Projects

  1. Dossier assessment

    Ibrutinib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)

    Project no.
    G14-11
    Last updated

    Status: Commission completed

  2. Dossier assessment

    Ibrutinib (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A16-60
    Last updated

    Status: Commission completed

  3. Dossier assessment

    Ibrutinib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A16-39
    Last updated

    Status: Commission completed

  4. Dossier assessment

    Ibrutinib - Benefit assessment according to §35a Social Code Book V

    Project no.
    A16-04
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form